AFC-HD AMS Life Science Co

AFC-HD AMS Life Science Co Dividend Coverage

The Dividend Coverage Ratio of AFC-HD AMS Life Science Co (2927.T) as of Nov 22, 2026 is 2.99. In the previous year, Dividend Coverage Ratio was 2.97 — a change of 0.89% (higher).

Dividend Coverage

2.99

YoY

0.89%

Last updated:

Dividend Coverage Ratio of AFC-HD AMS Life Science Co is 2025 2.99 . Dividend Coverage Ratio of AFC-HD AMS Life Science Co was 2024 2.97 . It decreases by 0.89% higher compared to the previous year.

The AFC-HD AMS Life Science Co Dividend Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend Coverage
Date
Dividend Coverage
Jan 1, 2018
2.62 JPY
Jan 1, 2019
2.78 JPY
Jan 1, 2020
2.42 JPY
Jan 1, 2021
3.82 JPY
Jan 1, 2022
1.74 JPY
Jan 1, 2023
2.87 JPY
Jan 1, 2024
2.97 JPY
Jan 1, 2025
2.99 JPY
The AFC-HD AMS Life Science Co Dividend Coverage history
YEARDividend CoverageYoY
2.99+0.89%
2.97+3.37%
2.87+64.45%
1.74-54.32%
3.82+57.50%
2.42-12.93%
2.78+6.33%
2.62-31.93%
3.85-4.84%
4.04-19.14%
5.00+110.97%
2.37—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

AFC-HD AMS Life Science Co Stock analysis

What does AFC-HD AMS Life Science Co do? AFC-HD AMS Life Science Co., Ltd. generates revenue through its Healthcare segment, which produces and sells health foods, cosmetics, and OEM services for other brands. The Pharmaceutical segment manufactures and sells ethical drugs, over-the-counter drugs, and generic medicines. The company also manages restaurants via a subsidiary, contributing to its diversified income streams. Customers include businesses seeking OEM partnerships and consumers purchasing health and pharmaceutical products. The firm's products are sold under its own brand and through OEM agreements, targeting both individual consumers and corporate clients. The Healthcare segment focuses on wellness products, while the Pharmaceutical segment caters to medical needs with prescription and non-prescription drugs. The restaurant management subsidiary provides additional revenue from food service operations. Revenue is derived from the sale of health foods, cosmetics, Chinese medicine medicines, general medicines, and healthcare products within the Healthcare segment. The Pharmaceutical segment's income comes from ethical drugs, over-the-counter drugs, and generic medicines. The restaurant subsidiary's operations further support the company's financial structure through food service sales. AFC-HD AMS Life Science Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AFC-HD AMS Life Science Co stock

Dividend Coverage Ratio of AFC-HD AMS Life Science Co is 2.99 in 2025.

Dividend Coverage Ratio of AFC-HD AMS Life Science Co changed from 2.97 to 2.99, representing a 0.89% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio AFC-HD AMS Life Science Co since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's AFC-HD AMS Life Science Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — AFC-HD AMS Life Science Co

All Key Metrics — AFC-HD AMS Life Science Co